1. Analysis of predictors of response to ruxolitinib in patients with myelofibrosis in the phase 3b expanded-access JUMP study. Issue 4 (21st March 2021) Authors: Gupta, Vikas; Griesshammer, Martin; Martino, Bruno; Foltz, Lynda; Tavares, Renato; Al-Ali, Haifa Kathrin; Giraldo, Pilar; Guglielmelli, Paola; Lomaia, Elza; Bouard, Catherine; Paley, Carole; Tiwari, Ranjan; Zor, Evren; Raanani, Pia Journal: Leukemia & lymphoma Issue: Volume 62:Issue 4(2021) Page Start: 918 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparing the safety and efficacy of ruxolitinib in patients with Dynamic International Prognostic Scoring System low‐, intermediate‐1‐, intermediate‐2‐, and high‐risk myelofibrosis in JUMP, a Phase 3b, expanded‐access study. Issue 4 (5th July 2021) Authors: Passamonti, Francesco; Gupta, Vikas; Martino, Bruno; Foltz, Lynda; Zaritskey, Andrey; Al‐Ali, Haifa Kathrin; Tavares, Renato; Maffioli, Margherita; Raanani, Pia; Giraldo, Pilar; Griesshammer, Martin; Guglielmelli, Paola; Bouard, Catherine; Paley, Carole; Tiwari, Ranjan; Vannucchi, Alessandro M. Journal: Hematological oncology Issue: Volume 39:Issue 4(2021) Page Start: 558 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Primary analysis of JUMP, a phase 3b, expanded‐access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts. (4th February 2020) Authors: Al‐Ali, Haifa Kathrin; Griesshammer, Martin; Foltz, Lynda; Palumbo, Giuseppe A.; Martino, Bruno; Palandri, Francesca; Liberati, Anna Marina; le Coutre, Philipp; García‐Hernández, Carmen; Zaritskey, Andrey; Tavares, Renato; Gupta, Vikas; Raanani, Pia; Giraldo, Pilar; Hänel, Mathias; Damiani, Danie... Journal: British journal of haematology Issue: Volume 189:Number 5(2020) Page Start: 888 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Severe thrombocytopenia as a predictor of survival and response to hypomethylating agents in myelodysplastic syndromes: A Latin‐American cohort of 212 patients. Issue 12 (1st October 2020) Authors: Lazzarino, Carolina; Arbelbide, Jorge; Schuster, Sergio; Crisp, Renée; González, Jacqueline; Tavares, Renato; Perusini, Maria Agustina; Di Stefano, Marco; Pintos, Noemí; Espinosa, Daniel; Pimentel, Mayra; Rosenhain, Mariana; Serrano, Juan Carlos; Enrico, Alicia; Iastrebner, Marcelo; Belli, Caroli... Journal: American journal of hematology Issue: Volume 95:Issue 12(2020:Dec.) Page Start: E323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗